Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation
Chronic diseases are characterised by altered autophagy and protein metabolism disarrangement, resulting in sarcopenia, hypoalbuminemia and hypo-haemoglobinaemia. Hypo-haemoglobinaemia is linked to a worse prognosis independent of the target organ affected by the disease. Currently, the cornerstone...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-01-01
|
| Series: | Nutrients |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6643/13/1/237 |
| _version_ | 1797411012735926272 |
|---|---|
| author | Evasio Pasini Giovanni Corsetti Claudia Romano Roberto Aquilani Tiziano Scarabelli Carol Chen-Scarabelli Francesco S. Dioguardi |
| author_facet | Evasio Pasini Giovanni Corsetti Claudia Romano Roberto Aquilani Tiziano Scarabelli Carol Chen-Scarabelli Francesco S. Dioguardi |
| author_sort | Evasio Pasini |
| collection | DOAJ |
| description | Chronic diseases are characterised by altered autophagy and protein metabolism disarrangement, resulting in sarcopenia, hypoalbuminemia and hypo-haemoglobinaemia. Hypo-haemoglobinaemia is linked to a worse prognosis independent of the target organ affected by the disease. Currently, the cornerstone of the therapy of anaemia is iron supplementation, with or without erythropoietin for the stimulation of haematopoiesis. However, treatment strategies should incorporate the promotion of the synthesis of heme, the principal constituent of haemoglobin (Hb) and of many other fundamental enzymes for human metabolism. Heme synthesis is controlled by a complex biochemical pathway. The limiting step of heme synthesis is D-amino-levulinic acid (D-ALA), whose availability and synthesis require glycine and succinil-coenzyme A (CoA) as precursor substrates. Consequently, the treatment of anaemia should not be based only on the sufficiency of iron but, also, on the availability of all precursor molecules fundamental for heme synthesis. Therefore, an adequate clinical therapeutic strategy should integrate a standard iron infusion and a supply of essential amino acids and vitamins involved in heme synthesis. We reported preliminary data in a select population of aged anaemic patients affected by congestive heart failure (CHF) and catabolic disarrangement, who, in addition to the standard iron therapy, were treated by reinforced therapeutic schedules also providing essential animo acids (AAs) and vitamins involved in the maintenance of heme. Notably, such individualised therapy resulted in a significantly faster increase in the blood concentration of haemoglobin after 30 days of treatment when compared to the nonsupplemented standard iron therapy. |
| first_indexed | 2024-03-09T04:38:50Z |
| format | Article |
| id | doaj.art-30a527e4eb8e407580351ff61c6e644b |
| institution | Directory Open Access Journal |
| issn | 2072-6643 |
| language | English |
| last_indexed | 2024-03-09T04:38:50Z |
| publishDate | 2021-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Nutrients |
| spelling | doaj.art-30a527e4eb8e407580351ff61c6e644b2023-12-03T13:24:09ZengMDPI AGNutrients2072-66432021-01-0113123710.3390/nu13010237Management of Anaemia of Chronic Disease: Beyond Iron-Only SupplementationEvasio Pasini0Giovanni Corsetti1Claudia Romano2Roberto Aquilani3Tiziano Scarabelli4Carol Chen-Scarabelli5Francesco S. Dioguardi6Cardiac Rehabilitation Division, Scientific Clinical Institutes Maugeri, IRCCS Lumezzane, Lumezzane, 25065 Brescia, ItalyDivision of Human Anatomy and Physiopathology, Department of Clinical and Experimental Sciences, University of Brescia, 25065 Brescia, ItalyDivision of Human Anatomy and Physiopathology, Department of Clinical and Experimental Sciences, University of Brescia, 25065 Brescia, ItalyDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, ItalyCenter for Heart and Vessel Preclinical Studies, St. John Hospital and Medical Center, Wayne State University, Detroit, MI 48202, USADivision of Cardiology, Richmond Veterans Affairs Medical Center (VAMC), Richmond, VA 23249, USADepartment of Internal Medicine, University of Cagliari, 9128 Cagliari, ItalyChronic diseases are characterised by altered autophagy and protein metabolism disarrangement, resulting in sarcopenia, hypoalbuminemia and hypo-haemoglobinaemia. Hypo-haemoglobinaemia is linked to a worse prognosis independent of the target organ affected by the disease. Currently, the cornerstone of the therapy of anaemia is iron supplementation, with or without erythropoietin for the stimulation of haematopoiesis. However, treatment strategies should incorporate the promotion of the synthesis of heme, the principal constituent of haemoglobin (Hb) and of many other fundamental enzymes for human metabolism. Heme synthesis is controlled by a complex biochemical pathway. The limiting step of heme synthesis is D-amino-levulinic acid (D-ALA), whose availability and synthesis require glycine and succinil-coenzyme A (CoA) as precursor substrates. Consequently, the treatment of anaemia should not be based only on the sufficiency of iron but, also, on the availability of all precursor molecules fundamental for heme synthesis. Therefore, an adequate clinical therapeutic strategy should integrate a standard iron infusion and a supply of essential amino acids and vitamins involved in heme synthesis. We reported preliminary data in a select population of aged anaemic patients affected by congestive heart failure (CHF) and catabolic disarrangement, who, in addition to the standard iron therapy, were treated by reinforced therapeutic schedules also providing essential animo acids (AAs) and vitamins involved in the maintenance of heme. Notably, such individualised therapy resulted in a significantly faster increase in the blood concentration of haemoglobin after 30 days of treatment when compared to the nonsupplemented standard iron therapy.https://www.mdpi.com/2072-6643/13/1/237chronic diseasesiron deficiencyhaemoglobinanaemiaaminoacidsrehabilitation |
| spellingShingle | Evasio Pasini Giovanni Corsetti Claudia Romano Roberto Aquilani Tiziano Scarabelli Carol Chen-Scarabelli Francesco S. Dioguardi Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation Nutrients chronic diseases iron deficiency haemoglobin anaemia aminoacids rehabilitation |
| title | Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation |
| title_full | Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation |
| title_fullStr | Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation |
| title_full_unstemmed | Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation |
| title_short | Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation |
| title_sort | management of anaemia of chronic disease beyond iron only supplementation |
| topic | chronic diseases iron deficiency haemoglobin anaemia aminoacids rehabilitation |
| url | https://www.mdpi.com/2072-6643/13/1/237 |
| work_keys_str_mv | AT evasiopasini managementofanaemiaofchronicdiseasebeyondirononlysupplementation AT giovannicorsetti managementofanaemiaofchronicdiseasebeyondirononlysupplementation AT claudiaromano managementofanaemiaofchronicdiseasebeyondirononlysupplementation AT robertoaquilani managementofanaemiaofchronicdiseasebeyondirononlysupplementation AT tizianoscarabelli managementofanaemiaofchronicdiseasebeyondirononlysupplementation AT carolchenscarabelli managementofanaemiaofchronicdiseasebeyondirononlysupplementation AT francescosdioguardi managementofanaemiaofchronicdiseasebeyondirononlysupplementation |